Kazuki Yoshida, MD, MPH, ScD: Methotrexate Access in the Post-Roe v Wade Era
Published: December 1, 2022 Rheumatology Network Read the Full Article >> In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or[…]